SEED Advances Cancer Drug as Human Trial Reaches Third Cohort
KING OF PRUSSIA, PA — SEED Therapeutics has advanced its experimental cancer treatment into a third dosing cohort in a first-in-human clinical trial, establishing early evidence that the drug degrades …
SEED Advances Cancer Drug as Human Trial Reaches Third Cohort Read More